Market Trends of Pharma Packaging Machinery Industry
This section covers the major market trends shaping the Pharma Packaging Machinery Market according to our research experts:
The Presence of Safety Standards & Regulations in the Pharmaceutical Industry Expected to Drive the Market
- The pharmaceutical industry is highly regulated and is emphasizing the safety and sustainability aspects of manufacturing and packaging processes. Traceability legislations across the healthcare sector have been established to counter counterfeit drugs and medical devices.
- For instance, the US Food and Drug Administration (FDA) regulates the manufacturing of drugs in the United States. It ensures the quality of drug products by carefully monitoring drug manufacturers' compliance with its Current Good Manufacturing Practice (CGMP) regulations. The CGMP regulations for drugs have set the minimum requirements for the methods, facilities, and controls used in the manufacturing, processing, and packaging of a drug.
- Similarly, the EU regulations mandate all pharmaceutical manufacturers to comply with the EU Good Manufacturing Practices (GMP), if they want to supply products to the EU. The manufacturers and importers must be authorized and registered by a competent authority from a member state. The manufacturers and importers are regularly inspected by an EU competent authority or other approved authority to check the compliance with the EU GMP. Hence, the presence of such regulations further necessitates the need for well-maintained and advanced packaging machinery to avoid product recalls.
Understand The Key Trends Shaping This Market
Download Sample
North America Hold a Significant Market Share
- The North American region is expected to dominate the market in terms of demand for advanced packaging machinery for the pharma industry, owing to the significant growth of the pharmaceutical industry in the region, thereby driving the manufacturing of drugs in the region. Also, the United States is the largest market for drugs worldwide and accounts for about half of the R&D expenditure in the pharmaceutical and biotechnology markets.
- It is observed that the development of COVID-19 vaccines has led the allied companies to set up agreements with packaging companies for manufacturing syringes and vials. Such packaging trends acts as a major driver of growth in the packaging equipment market.
- Also, expanding capacities for vaccines has led the allied packaging engineering companies and OEMs witness an increasing demand for aseptic filling lines. in a response to such trends, pharaceutical packaging machinery players are launching fully integrated systems, plug-and-play solutions with modular concepts.
- Furthermore, according to IQVIA, a human data science company, pharmaceutical sales worldwide are anticipated to reach USD 1.5 trillion in 2023 from USD 491 billion in 2019. The United States dominates the pharmaceutical market, both in consumption and development. According to STAT, prescription drug spending in the nation is considered to add up to USD 600 billion by 2023, up from an estimated USD 500 billion in 2019.
- The need to have proper infrastructure for the safe handling and safe containment of highly potent drugs, as well as the need for suitable analytical capabilities, particularly for high potency drugs, proper project management (that includes proper induction, running, and completion) highlight the need for R&D. Such trends are expected to boost the demand for packaging machinery in the region, with the growing manufacturing of drugs in the region.
Get Analysis on Important Geographic Markets
Download Sample
